LoginRegister

    JB Chemicals and Pharma gets USFDA nod for hypertension tablets

    Written by Ruby Khatun Khatun   |  
    JB Chemicals and Pharma gets USFDA nod for hypertension tablets

    New Delhi: JB Chemicals & Pharmaceuticals has received US health regulator's nod for Atenolol tablets, used in the treatment of high blood pressure.


    "The United States Food and Drug Administration (USFDA) has approved the company's supplementary Abbreviated New Drug Application (ANDA) for Atenolol tablets USP 25mg, 50mg and 100 mg," JB Chemicals & Pharmaceuticals said in a BSE filing.

    The company, which plans to commercialize this product in the next quarter, said the market for the approved product is about USD 70 million.

    "The company is focused on US business and this approval will help the company grow its exports," it added.
    Abbreviated New Drug ApplicationapprovalAtenolol tabletsFood and Drug Administrationhigh blood pressurehypertension tabletsindian pharma newsJB Chemicals & PharmaceuticalsJB Chemicals and PharmaJB Chemicals and Pharmaceuticalspharma newspharma news indiaUSFDA
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X